Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arcoxia vs Voltaren Resinat in Total Hip Arthroplasty
NCT01229774Phase 3Completed
- Sponsor
- University of Regensburg
- Start
- Feb 2011
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of etoricoxib in postoperative pain, Bleeding and heterotopic ossification (HO), sponsored by University of Regensburg. Primary endpoint: Perioperative blood loss at 3 days. Started Feb 2011; status: completed.
02
Drugs
etoricoxib
03
Conditions
postoperative painBleedingheterotopic ossification (HO)
Beyond the preview
Go deeper on NCT01229774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229774.